Session II
Basic science II

Programme

• 17:00 – 17:10 10 Min. 0 Min.

  • Invited lecture

  Welcome talk

  • Prof. Jörg C. Kalff (Bonn / DE)
• 17:10 – 17:20 8 Min. 2 Min.

  • Oral presentation
  • O10

  Crosstalk of glutamine metabolism and NFATc1 – unfolding vulnerabilities for enhanced therapeutic efficacy in PDAC

  • Laura Melissa Huhnold (Göttingen / DE)

   Pancreatic cancer
• 17:20 – 17:30 8 Min. 2 Min.

  • Oral presentation
  • O11

  Coculture of pancreatic stellate and pancreatic adenocarcinoma cells: metabolic characterization in vitro and in vivo

  • Alina Doctor (Dresden / DE)

   Pancreatic cancer
• 17:30 – 17:40 8 Min. 2 Min.

  • Oral presentation
  • O13

  Integrin-mediated tumor-stroma interfacial signaling promotes basal-like and immune exclusion phenotype in pancreatic ductal adenocarcinoma

  • Prof. Yifeng Sun (Heidelberg / DE)

   Pancreatic cancer
• 17:40 – 17:50 8 Min. 2 Min.

  • Oral presentation
  • O14

  IL-17A-producing CD8+ T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts

  • Dr. Magdalena Huber (Marburg / DE)

   Tumour microenvironment, epigenetics and stem cells
• 17:50 – 18:00 8 Min. 2 Min.

  • Oral presentation
  • O15

  The roles of GalNT2 and St3Gal6 genes on neural invasion

  • Alper Dogruöz (München / DE)

   Pancreatic cancer
• 18:00 – 18:10 8 Min. 2 Min.

  • Oral presentation
  • O16

  CCN1/CYR61 is an important player in the crosstalk between Panc1 cells and pancreartic stellate cells/CAFs affecting chemoresistance to gemcitabine

  • Rainer Heuchel (Huddinge / SE)

   Pancreatic cancer
• 18:10 – 18:20 8 Min. 2 Min.

  • Oral presentation
  • O17

  Tumor-immune-microenvironmental implications of targeted SHP2-inhibition +/- MAPK-inhibition in pancreatic cancer

  • Mrs Asma Alrawashdeh (Freiburg / DE)

   Pancreatic cancer